Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza in hypertriglyceridemia
NCT01180764Phase 4Withdrawn
- Sponsor
- University of Utah
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertriglyceridemia comparing Lovaza with Placebo (2 arms). Primary endpoint: HDL Composition at 12 weeks. Planned start Aug 2010; status: withdrawn.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01180764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180764.